[Second line chemotherapy of carcinoma of the ovary. Current approaches].
In the present work, on the basis of the most recent knowledges, the Authors analyse and discuss the pharmacological and clinical aspects of the different types of second-line chemotherapeutical treatment for refractory ovarian cancer (standard single agent chemotherapy in high-dose schedules, new investigational anticancer agents, multidrugs chemotherapy, intraperitoneal chemotherapy).
Sesti
F
F
Mantenuto
L
L
Ciancaglini
G
G
Zupi
E
E
Terenzi
S
S
Piccione
E
E
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents
Chemioterapia di seconda linea del carcinoma ovarico. Orientamenti attuali.